Skip to main content

Animations

MJFF Publications

4951 - 4960 of 6466 Results
Title
Year
  • Year
  • 2017
  • 2017
  • 2019
  • 2020
  • 2019
  • 2023
  • 2019
  • 2023
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Prediction of cognition in Parkinson's disease with a clinical–genetic score: a longitudinal analysis of nine cohorts
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(17)30122-9
    Citation Count: 189
  • Summary Details
    OPEN
    Title: Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(17)30328-9
    Citation Count: 159
  • Summary Details
    OPEN
    Title: Increased striatal dopamine in carriers of GBA mutations: compensation or epiphenomenon?
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30355-2
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Developing therapies for Parkinson's disease
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(20)30320-3
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30319-9
    Citation Count: 139
  • α-synuclein seed amplification in Parkinson's disease – Authors' reply
    2023
    Summary Details
    OPEN
    Title: α-synuclein seed amplification in Parkinson's disease – Authors' reply
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00371-x
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study
    Journal Name: The Lancet Digital Health
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s2589-7500(19)30105-0
    Citation Count: 119
  • Summary Details
    OPEN
    Title: α-synuclein seed amplification in Parkinson‘s disease
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00374-5
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Estimating brain age based on a uniform healthy population with deep learning and structural magnetic resonance imaging
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.02.009
    Citation Count: 100
  • Summary Details
    OPEN
    Title: The role of RHOT1 and RHOT2 genetic variation on Parkinson disease risk and onset
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2020.07.003
    Citation Count: 10
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.